Sign in
Taking people in United StatesNo phase

Broccoli Microgreens Tested in Obese Breast Cancer Survivors

Tests a daily broccoli microgreen food serving in obese breast cancer survivors.

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the site
Trial code
Registry title
Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
Status
Recruiting
People taking part
24 people, planned
Started
3 Dec 2025
Expected to end
31 Dec 2028
Type of study
Interventional
Treatments tested
  • Broccoli microgreen (BMG)
Record updated
23 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with obesity who had stage I-III breast cancer and finished treatment 2 to 60 months ago. They eat a serving of broccoli microgreens every day for two weeks.

Sex
Women only.
Disease stage
Breast cancer, stage I-III, in the past.
Earlier treatment
Finished treatment meant to remove the cancer (surgery, chemotherapy and/or radiation) 2 to 60 months ago.
Biomarker or test result
BMI above 30 kg/m².

Main reasons for not taking part

  • Any medical reason that makes the diet unsafe, such as stomach or bowel conditions, pregnancy, breastfeeding or a recent eating disorder
  • Allergy or intolerance to cruciferous vegetables
  • Currently taking broccoli extract supplements
  • Not willing to avoid cruciferous vegetables during the study

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Female
  • Had a diagnosis of breast cancer (Stage I-III)
  • 2 to 60 months post-curative treatment (surgery, chemotherapy, and/or radiation)
  • BMI > 30 kg/m² (obese classification)
  • Willing to avoid cruciferous vegetables during the study
  • Able to sign an IRB-approved consent form

Who cannot take part

  • Currently taking broccoli extract supplements
  • Have any contraindications to the proposed nutrition intervention as identified by their medical provider, their designee, or the study team (e.g., GI conditions, medication requirements, pregnancy, breastfeeding, recent history of an eating disorder)
  • Allergy or intolerance to cruciferous vegetables

Where in United States

  • Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer CenterBaltimore, United StatesContact: Katherine TkaczukTaking people

About the trial

What the trial wants to find out

Obesity can pose significant challenges to maintaining long-term health in cancer survivors by increasing their risk of cancer coming back. Eating a healthy diet is an important way to help manage weight and improve overall health. Broccoli microgreens (BMG) are young broccoli plants packed with nutrients, and research suggests they may help prevent cancer.

Read full original descriptionShow less

Previous studies in mice showed that BMG can improve gut health and metabolism, leading to better health outcomes in obese animals. This study will test whether BMG can be a useful addition to the diet of obese breast cancer (BC) survivors who have a higher risk of their cancer returning.

24 obese BC survivors will be invited to eat one serving (one cup, ~57 gram) of fresh BMG every day for two weeks. This will help understand if people can stick to this diet, how their bodies respond, and whether it affects metabolism and inflammation-two key factors linked to cancer risk. Biological markers such as body fat, glucose and lipids as well as gut bacterial changes will be analyzed to see how BMG affects individual health.

This study may help create new diet strategies to improve health, reduce cancer risk, and support long-term recovery in cancer patients who are overweight or obese. In the future, this research could help doctors personalize nutrition plans to better support cancer survivors.

The group in the trial

  • BMGTreatment being tested

    All participants are in BMG group and will consume one serving size (one cup, \~57 gram) of raw BMG daily for 2-week period of time.

    Treatment: Broccoli microgreen (BMG)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Metabotyping of a Functional Food, Broccoli Microgreen, in Obese Breast Cancer Survivors
Plain-language title
Broccoli Microgreens Tested in Obese Breast Cancer SurvivorsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
23 December 2025